{"disease":{"id":"neoadjuvent","name":"neoadjuvent"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06006650","title":"Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":114,"lead_sponsor_name":"Tang-Du Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}